Long term administration of selective NMDA GluN2B receptor blocker Ro25-6981 attenuates neurodegeneration in mouse model of spinocerebellar ataxia type 1 (SCA1). - Belozor OS; Mileiko AG; Mosina LD; Mikhailov IG; Mikhailova MS; Khilazeva ED; Ox DA; Grinev ES; Boitsova EB; Shuvaev AN; Teschemacher AG; Kasparov S (Cell death discovery, 2026)